The Second Pilot of the CoCoCare Course Has Started!
Get a glimpse of the key highlights, insights, and standout moments from EAN 2025 in Helsinki, all captured in our Congress Review eBook.
Latest Posts
-
-
EAN NewsResident and Research FellowsTop 10 ArticlesNews in generalEducation cornerEAN is proud to announce the 2020 Virtual Master Classes Christmas Special
As a Christmas Special to EAN’s Resident and Research Fellow Section (RRFS) members, we are hosting our first series of Virtual Master Classes in the course of December 2020 for free. -
Breaking newsEAN NewsCOVID-19ResearchCOVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management
COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management -
Breaking newsEAN NewsCOVID-19ResearchThe temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries
The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries -
Breaking newsEAN NewsCOVID-19ResearchIschemic Stroke Occurs Less Frequently in Patients With COVID-19 A Multicenter Cross-Sectional Study
Ischemic Stroke Occurs Less Frequently in Patients With COVID-19 A Multicenter Cross-Sectional Study -
Breaking newsEAN NewsCOVID-19ResearchEXPRESS: Stroke in COVID-19: a systematic review and meta-analysis
EXPRESS: Stroke in COVID-19: a systematic review and meta-analysis -
Breaking newsEAN NewsCOVID-19ResearchNew onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review
New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review -
Breaking newsEAN NewsCOVID-19Research
Severe COVID-19-related encephalitis can respond to immunotherapy.
Severe COVID-19-related encephalitis can respond to immunotherapy. -
Breaking newsEAN NewsCOVID-19Research
The cognitive consequences of the COVID-19 epidemic: collateral damage?
The cognitive consequences of the COVID-19 epidemic: collateral damage? -
Breaking newsEAN NewsCOVID-19Research
Death Rate Due to COVID-19 in Alzheimer’s Disease and Frontotemporal Dementia
Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia -
Breaking newsEAN NewsCOVID-19
Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series
Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series -
Breaking newsEAN NewsCOVID-19Research
Immunology of COVID-19 and disease-modifying therapies: the good, the bad and the unknown
Immunology of COVID-19 and disease-modifying therapies: the good, the bad and the unknown -
Breaking newsEAN NewsCOVID-19Research
Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses
Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses -
Breaking newsEAN NewsCOVID-19Research
CSF biomarkers in patients with COVID-19 and neurological symptoms A case series
CSF biomarkers in patients with COVID-19 and neurological symptoms A case series -
Breaking newsEAN NewsCOVID-19Research
COVID-19 impact on consecutive neurological patients admitted to the emergency department
COVID-19 impact on consecutive neurological patients admitted to the emergency department